Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026
Globe Newswire•03/08/2026•08:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.